Circulating tumour DNA in blood a valid option for EGFR testing in patients who do not have accessible tumour tissue
Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers has reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland. The results have important implications for the use of cancer […]
